Document Detail

Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer.
MedLine Citation:
PMID:  23212424     Owner:  NLM     Status:  Publisher    
The purpose of this study was to clarify the distribution of epidermal growth factor receptor (EGFR) mutations between primary tumors (PT) and metastatic lymph node (MLN) in patients with resected non-small cell lung cancer (NSCLC) and to identify a better predictive marker of the response to EGFR tyrosine kinase inhibitor (EGFR-TKI). We conducted a retrospective review of the data of 70 lung cancer patients with lymph node metastasis who underwent surgical resection. Analysis to detect EGFR mutations was performed by a peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp method. EGFR mutations were detected in 15.7 % of both the PT and MLN and in 14.3 % of the PT only. The response rate to EGFR-TKI tended to be higher in patients with EGFR mutations in the MLN, as all patients with EGFR mutations in the MLN showed disease control to treatment with EGFR-TKI. Our results demonstrated that the EGFR mutation status of MLN is a predictive marker of the response to EGFR-TKI therapy in patients with recurrent NSCLC after surgical resection.
Katsuhiko Shimizu; Takuro Yukawa; Yuji Hirami; Riki Okita; Shinsuke Saisho; Ai Maeda; Koichiro Yasuda; Masao Nakata
Related Documents :
24516754 - The p53 mutation/deletion profile in a small cohort of the omani population with diffus...
23438214 - Mutation spectrum of dystrophin gene in malaysian patients with duchenne/becker muscula...
24955184 - Association between gene polymorphisms in tim1, tslp, il18r1 and childhood asthma in tu...
14502374 - Thr(118)met amino acid substitution in the peripheral myelin protein 22 does not influe...
23203104 - Rapid development of microsatellite markers for the endangered fish schizothorax biddul...
9568784 - Mutations of p53 in gallbladder carcinomas in high-incidence areas of japan and chile.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-5
Journal Detail:
Title:  Targeted oncology     Volume:  -     ISSN:  1776-260X     ISO Abbreviation:  Target Oncol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101270595     Medline TA:  Target Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of General Thoracic Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biomolecular coronas provide the biological identity of nanosized materials.
Next Document:  Establishing the content validity of palpatory examination for the assessment of the lumbar spine us...